logo
Rigetti vs. IBM: Which Quantum Computing Stock Has Better Prospects?

Rigetti vs. IBM: Which Quantum Computing Stock Has Better Prospects?

Yahooa day ago

As quantum computing inches closer to practical, real-world applications, investors are turning their attention to the companies leading the charge in this transformative technology. Rigetti Computing RGTI and International Business Machines Corporation IBM are two prominent players in the quantum space, each with distinct approaches and advantages. Rigetti, a nimble startup, focuses on building cutting-edge quantum processors and scalable systems, while IBM leverages its decades-long expertise and vast resources to develop a comprehensive quantum ecosystem that integrates hardware, software, and cloud services.
Both companies are rapidly expanding their quantum capabilities and securing partnerships with governments, research institutions, and enterprises eager to use quantum power. As the quantum computing market shifts from experimental research to commercial use, this faceoff compares Rigetti and IBM on technology, business models, and growth strategies, helping investors identify which stock offers better long-term upside in the emerging quantum era.
Shares of Rigetti have plunged 8.2%, while IBM stock has gained 17.6% in the year-to-date period.
Image Source: Zacks Investment Research
From a valuation standpoint, IBM looks more attractive than RGTI. According to the price/book ratio, IBM's shares currently trade at 8.92, lower than 19.43 for Rigetti.
Image Source: Zacks Investment Research
Rigetti uses a modular quantum architecture that scales by linking smaller chips. Its latest Ankaa-3 system features 84 superconducting qubits with approximately 99.5% two-qubit gate fidelity, enabled by its proprietary ABAA process. Rigetti emphasizes AI-assisted calibration and error reduction to boost performance. It plans to launch a 36-qubit system in mid-2025 and exceed 100 qubits by year-end. Though innovative, its systems remain smaller in scale compared to industry leaders.
IBM deploys a highly integrated quantum stack, led by its 133-qubit Heron processor, which improves error rates and reduces crosstalk over its Eagle predecessor. Its modular architecture supports interconnecting processors like the 1,121-qubit Condor, forming the backbone of Quantum System Two for scalable hybrid computing. With strong cloud integration, global infrastructure, and developer support via Qiskit, IBM remains a leader in practical, scalable quantum technology.
Rigetti adopts a focused, hardware-first business model tailored to quantum computing, centered around its proprietary modular chip architecture and cloud-based Quantum Cloud Services. It monetizes through direct system access, strategic partnerships, and integration with platforms like Amazon Braket and Azure Quantum. Rigetti targets niche enterprise and research segments, offering flexible deployment and AI-assisted system calibration.
In contrast, IBM leverages its vast resources to deliver a full-stack quantum computing model, combining hardware, software (Qiskit), and services under the IBM Quantum Platform. It commercializes through cloud access, consulting, and its 280+ member IBM Quantum Network, which includes Fortune 500 firms and academic institutions. With over $1 billion in cumulative quantum revenue and multi-billion-dollar R&D investments, IBM's business model emphasizes ecosystem dominance, global infrastructure, and long-term enterprise integration.
Rigetti's growth strategy centers on scaling modular quantum systems, advancing hardware via ABAA fabrication and AI calibration, and targeting a 108-qubit system by the end of 2025 with halved error rates. It is expanding manufacturing through a $250M Quanta partnership and boosting cloud integration to widen access. While innovation-driven and agile, the strategy is limited by financial constraints and a smaller customer base.
IBM's growth strategy focuses on quantum-centric supercomputing via a long-term roadmap, interconnecting modular chips like the 1,121-qubit Condor to achieve fault tolerance. It targets quantum advantage by 2026 through efforts like the '100×100 challenge' and Quantum System Two. Leveraging global infrastructure, enterprise partnerships, and strong R&D funding, IBM prioritizes scalability, reliability, and commercial adoption worldwide.
The Zacks Consensus Estimate for RGTI's 2025 sales implies a year-over-year decline of 18.63%. For 2025, loss per share is projected to be 5 cents compared with 36 cents a year ago. The earnings estimates have been trending upward over the past 60 days.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for IBM's 2025 sales and earnings implies year-over-year growth of 5.5% and 6%, respectively. The earnings estimates have been trending upward over the past 60 days.
Image Source: Zacks Investment Research
Both Rigetti and IBM are advancing in the quantum computing space, but they differ significantly in scale, strategy, and market positioning. IBM holds a Zacks Rank #3 (Hold) with a strong Growth Score of 'A', reflecting solid potential driven by its expansive infrastructure, global partnerships, and ambitious quantum roadmap. Rigetti, on the other hand, carries a Zacks Rank #4 (Sell), indicating a challenging short-term prospect. However, its Growth score of 'B' reflects upside potential once the challenges subside.
While Rigetti remains a compelling small-cap innovator with modular architecture and technical focus, IBM's full-stack capabilities and enterprise reach give it an edge for investors seeking more stability and long-term commercial traction in the quantum sector. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Business Machines Corporation (IBM) : Free Stock Analysis Report
Rigetti Computing, Inc. (RGTI) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Arvinas, Inc. (ARVN)
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Arvinas, Inc. (ARVN)

Business Wire

timean hour ago

  • Business Wire

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Arvinas, Inc. (ARVN)

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that the firm is investigating potential claims against Arvinas, Inc. ('Arvinas' or the 'Company') (NASDAQ:ARVN). The firm's ongoing investigation concerns whether Arvinas and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. On May 1, 2025, Arvinas and its partner Pfizer announced that they would discontinue development of vepdegestrant, an oral SERD for HR-positive breast cancer. The move eliminated two planned Phase 3 studies, following the termination of VERITAC-3 in January. According to The Fly, a financial news platform, Oppenheimer & Co. 'was surprised by the announcement' and questioned whether 'Arvinas' management isn't telling us the whole story.' Arvinas had repeatedly pointed to clinical progress for vepdegestrant and the drug's commercial opportunity, leaving investors caught off guard by the abrupt pivot. On this news, the price of Arvinas shares declined by $2.39 per share, or approximately 25%, from $9.62 per share on April 30, 2025, to close at $7.23 on May 1, 2025. If you purchased or otherwise acquired Arvinas securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@ or fill out the contact form below to discuss your rights or interests with respect to these matters without any cost to you. [CONTACT FORM] Kirby McInerney LLP is a New York-based plaintiffs' law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm's efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Residents take home a piece of history as IBM buildings are demolished
Residents take home a piece of history as IBM buildings are demolished

Yahoo

timean hour ago

  • Yahoo

Residents take home a piece of history as IBM buildings are demolished

ENDICOTT, N.Y. (WIVT/WBGH) – Endicott residents had a chance to take home a piece of IBM history on Wednesday. The Village hosted Old Building Group Brick Day. A pile of bricks was made available for people to take as souvenirs. They came from the demolition of the former IBM factory buildings at the corner of North Street and McKinley Avenue. Big Blue was founded in Endicott and was a fixture of the local community for nearly 100 years, employing as many as 20,000 workers at one time. David Brennan, who works for Assemblywoman Donna Lupardo, says the brick is a great memento of our area's rich history of innovation. 'IBM is kind of what built Endicott. It is an integral part of our history, and to have a piece of what it was and a reminder of where it's going to go next is both optimistic and sentimental. It is just a good thing to have,' said Brennan. While IBM no longer has physical offices in our area, it still has some remote work employees. Demolition of the old factory buildings is nearing completion. Sneaker Drive honors the life of Noah Farrelly Residents take home a piece of history as IBM buildings are demolished Riley protecting Lisle dairy farmer betrayed by government Musicians from around the world celebrate Ukraine with free concert Rapist who killed Binghamton man in hit and run crash sentenced to prison Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

‘3%' Producer Boutique Filmes Teams With Ukbar, Diego Freitas on ‘Mistério do Cinco Estrellas' (EXCLUSIVE)
‘3%' Producer Boutique Filmes Teams With Ukbar, Diego Freitas on ‘Mistério do Cinco Estrellas' (EXCLUSIVE)

Yahoo

time3 hours ago

  • Yahoo

‘3%' Producer Boutique Filmes Teams With Ukbar, Diego Freitas on ‘Mistério do Cinco Estrellas' (EXCLUSIVE)

Brazil's Boutique Filmes, whose 2016 series '3%' was Netflix's first big non-English-language international breakout ever, is teaming to produce 'O Mistério do Cinco Estrelas' with Portugal's Ukbar Filmes ('Silent Cargo') and director Diego Freitas. Adapting celebrated Brazilian writer Marco Rey's 'O Mistério do Cinco Estrelas' is a murder-mystery set in a luxury hotel. More from Variety Netflix Brazil Unveils a 'Sintonia' Spin-Off, Soccer Shows on Brazil 1970, Ronaldinho and Neymar and a Scripted Series on Brazil's Biggest Ever Radioactive Disaster Exhibitors in Brazil Step Up Demand for Local Films With Walter Salles' 'I'm Still Here,' 'Noah's Ark' Among Potential Hits '3%' Producer Boutique Filmes Unveils 'Seven Women,' New Sci-Fi Show From Pedro Aguilera (EXCLUSIVE) Announced on the first day of Brazil's Rio2C where Boutique Filmes' founder-producer Tiago Melles will serve as a mentor on May 28, 'O Mistério do Cinco Estrelas' marks the second of two movies from Boutique announced in the space of two days. On Tuesday, Boutique unveiled 'O Gênio do Crime,' a co-production with Globo Filmes which follows the adventures of Gordo's Gang, a group of children who decide to investigate a criminal mastermind forging World Cup sticker albums. Paris Filmes is set to release in Brazil. The first to go into production and Boutique Filmes' first ever producer, 'O Gênio do Crime' will roll from July, filming in São Paulo. 'O Mistério do Cinco Estrelas' is scheduled for a first half 2026 shoot. In 'Mistério,' Leo, a young bellboy at the luxurious Emperor Park Hotel, stumbles upon a dead body in Room 222. When no one believes his story, he decides to investigate the crime on his own. Accused of being the murderer, he has to go on the run to prove his innocence. The story points up social equality, said Mello. 'Leo is from a humble background, serving the ultra-rich. Brazilian society, the police authorities treat the rich and poor differently in Brazil,' he said. Both 'Mistério' and 'Gênio' adapt major Brazilian literary IPs. Published in 1981, 'Mistério' reps a big screen makeover of one of the most iconic novels from Rey, in a year which marks the centenary of his birth, the book having just been re-released by Global Editora, with illustration by Oscar nominated Ali Abreu ('The Boy and the World'). Another classic, 'O Gênio do Crime', by João Carlos Marinho has sold over one million copies and gone through 60 editions. 'O Gênio do Crime' is 'a page-turner of a book, a novel that has proved remarkable for generations and generations of Brazilians. It is a dream come true to be in charge of this production with partners such as Globo Filmes and Paris Filmes,' said Tello, noting Boutique aims to make a film 'that combines adventure, humor and a coming of age story.' They both enrol top creative talent. Freitas directed two of Netflix's biggest recent movie smash-hits, 'Beyond the Universe' and 'Burning Betrayal.' 'O Gênio do Crime' will be helmed by Lipe Binder, an artistic director on 'Aruanas' and director of Globoplay Original 'Living On A Razor's Edge,' selected for last year's Berlinale Market Selects and a main director on Globoplay/AfroReggae Audiovisual smash hit 'Dissident Archangel.' Pedro Perazzo ('Freitas Brothers') wrote 'Mistério,' Ana Reber ('Beyond the Universe') is penning 'Gênio.' 'Mistério' targets a YA audience, said Mello describing it as a kind of Brazilian 'Goonies,' while 'Gênio' is made for kids & family at a time when such films are emerging as one of the strongest international bets for non-English language movies. Both titles have also received ProAC International Co-Production funding. An incentive initiative backed by São Paulo State to the tune of R$400 million ($70.8 million) a year and part of its Audiovisual Industry Development Plan which aims, among other objectives, to help create bigger scale international co-productions. 'O Gênio do Crime,' for example, will use the same production designer, Thales Junqueira, as Kleber Mendonça Filho's Cannes double winner 'The Secret Agent.' 'We wouldn't have been able to finance these titles without São Paulo State aid,' Mello said. Boutique Filmes is entering film production after Brazilian Movies have won prizes at the Berlin ('The Blue Trail') and Cannes ('The Secret Agent') festivals and the Academy Awards ('I'm Still Here'). In 2024, a presidential decree established exhibition quotas for Brazilian movies, encouraging exhibitors to keep local hits in cinema theaters. . 'I've been working on series for 20 years now. Entering theatrical film production can be interesting on a personal and company level, catching Brazilian cinema and theatrical distribution in Brazil at an incredible moment, making it very interesting to have long-run films and allowing a company to retain IP,' Mello told Variety, adding that the films are 'important in forming an audience in Brazil for national content.' Boutique will begin to talk with sales agents once the films go into production, he added. 'O Gênio do Crime' will be released next year before the 2026 soccer FIFA World Cup. Best of Variety 'Harry Potter' TV Show Cast Guide: Who's Who in Hogwarts? New Movies Out Now in Theaters: What to See This Week Emmy Predictions: Talk/Scripted Variety Series - The Variety Categories Are Still a Mess; Netflix, Dropout, and 'Hot Ones' Stir Up Buzz

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store